TO COMPARE THE EFFECT OF ROPIVACAINE & ROPIVACAINE WITH MAGNESIUM SULPHATE AS ADJUVANT IN USG GUIDED FASCIA ILIACA BLOCK FOR PATIENTS UNDERGOING PROXIMAL FEMUR FRACTURE SURGERY

Efficacy of Ropivacaine verses Ropivacaine with Magnesium Sulphate as Adjuvant in usg Guided Fascia Iliaca Block in Proximal Femur Fracture Surgery- A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052200

Enrollment

Registered

2023-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S720- Fracture of head and neck of femur Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: ROPIVACAINE WITH MAGNESIUM SULPHATE: FASCIA ILIACA BLOCK IN POST OPERATIVE PERIOD AND VAS SCORE WILL BE MONITORED EVERY TWO HOURLY TILL 24 HOURS TO BE INTERVENED FOR 1YEAR Control Inter

Eligibility

Inclusion criteria

Inclusion criteria: 1.AGE >18YEARS 2.PATIENTS POSTED FOR PROXIMAL FEMUR SURGERY

Exclusion criteria

Exclusion criteria: 1.ALLERGY 2.PATIENT WITH CHRONIC PAIN SYNDROME 3.ANALGESIC ABUSE 4.ADDICTION TO ALCOHOL/OPIODS 5.COAGULOPATHY 6.INFECTION/SEPSIS AT SITE OF INJECTION 7.SEVERE RENAL FAILURE 8.MYASTHENIA GRAVIS 9.PULMONARY EDEMA 10.HEART BLOCK

Design outcomes

Primary

Measure	Time frame
1.TIME REQUIRED FOR FIRST ANALGESIC DEMANDTimepoint: FIRST POST OPERATIVE DAY	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactKASTURI DASH

KALINGA INSTITUTE OF MEDICAL SCIENCE

lingaraj.sahu@kims.ac.in8249413544

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026